Esta información es solo con fines educativos. No constituye consejo médico. Consulte siempre a un profesional de salud cualificado.
Descripción, Dosificación, Efectos secundarios, Contraindicaciones. Data from EMA, URPL, openFDA and other regulatory sources.
| Ranitidine | Famotidine | |
|---|---|---|
| Sustancias activas | RANITIDINE HYDROCHLORIDE | FAMOTIDINE |
| Código ATC | A02BA02 | A02BA03 |
| Forma | TABLET | TABLET, FILM COATED |
| Dosificación | 300 mg/1 | 10 mg/1 |
| Vía de administración | ORAL | ORAL |
| Fabricante | Rising Pharma Holdings, Inc. | Safeway |
Ranitidine (INN: RANITIDINE HYDROCHLORIDE, ATC A02BA02) and Famotidine (INN: FAMOTIDINE, ATC A02BA03) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Esta información es solo con fines educativos. No constituye consejo médico. Consulte siempre a un profesional de salud cualificado.